Thu, May 25, 2017 | updated 12:20 PM IST

Immunotherapy doubles survival of head, neck cancer patients

Updated: Oct 09, 2016 13:52 IST      
Immunotherapy doubles survival of head, neck cancer patients

New Delhi [India], Oct. 9 (ANI): An immunotherapy drug has been hailed as a potential 'game changer' after being found to greatly improve survival for patients with relapsed head and neck cancer.

Nivolumab became the first treatment to extend survival in a phase III clinical trial for patients with head and neck cancer in whom chemotherapy had failed and it did so with fewer side-effects than existing therapeutic options, says a new research.

More than double the number of patients taking nivolumab were alive after one year as those treated with chemotherapy.

There are currently no other treatment options that improve the survival of patients with cisplatin-resistant relapsed or metastatic head and neck cancers.

This group of patients is expected to live less than six months.

The trial was led in the UK by Professor Kevin Harrington and involved 20 research organisations from around the world.

static head and neck cancer were allocated to receive nivolumab and 121 to one of three different chemotherapies.

UK patients received the chemotherapy drug docetaxel, which is the only treatment approved for advanced head and neck cancer by NICE.

After one year of the study, 36 percent of patients treated with nivolumab were still alive compared with 17 percent for the comparator arm.

Median survival for patients on nivolumab was 7.5 months, compared with 5.1 months for chemotherapy.

The survival benefit was more pronounced in patients whose tumours had tested positive for human papillomavirus (HPV).

These patients survived an average of 9.1 months with nivolumab and 4.4 months with chemotherapy.

HPV-negative patients survived an average of 7.5 months with nivolumab and 5.8 with chemotherapy.

Importantly, fewer patients experienced serious side-effects from taking nivolumab than with conventional treatment, only 13 percent compared with 35 percent of patients, who received chemotherapy.

Patients given chemotherapy reported feeling physically, socially and emotionally worse off, whereas those who were given nivolumab remained stable during the course of treatment.

Harrington said: "Nivolumab could be a real game-changer for patients with advanced head and neck cancer.

This trial found that it can greatly extend life among a group of patients who have no existing treatment options, without worsening quality of life."

"Once it has relapsed or spread, head and neck cancer is extremely difficult to treat. So it's great news that these results indicate we now have a new treatment that can significantly extend life, and I'm keen to see it enter the clinic as soon as possible," he added.

The research has been published in New England Journal of Medicine. (ANI)

New Delhi [India], May 25 (ANI): A Sutureless Valve Replacement surgery was recently performed on a 78 year old patient by Global Hospitals, Mumbai.

Full Story >>

Suicide rates among people with autism on rise

Updated: May 25, 2017 11:26 IST     

Washington D.C. [USA], May 25 (ANI): According to a recent study, suicide rates among autism patients have reached 'worryingly' high levels.

Full Story >>

Unhappy, less aware youth prone to alcohol addiction

Updated: May 25, 2017 10:36 IST     

Washington D.C. [USA], May 25 (ANI): Making youth aware of the harms of smoking and drinking could help them steer away from alcohol and cigarettes, suggests a recent study.

Full Story >>

London [UK], May 24 (ANI): Sleep is the easiest thing to forego by hardworking individuals. What we don't realize is, when sleep fails, one's health declines along with the quality of life.

Full Story >>

Washington D.C. [USA], May 24 (ANI): According to a recent study, adequate levels of Vitamin D combined with good sleep can help you manage chronic arthritis and back pain.

Full Story >>

Washington D.C. [USA], May 24 (ANI): You might consider yourself to be a recreational user but could be further along the road to drug addiction than you might have realized, a study suggests.

Full Story >>

Washington D.C. [USA], May 24 (ANI): A recent study shows a multi-protein biomarker blood test to detect breast cancer can potentially reduce use of biopsy up to 67percent.

Full Story >>

Childhood obesity results in early onset of arthritis

Updated: May 24, 2017 09:32 IST     

New Delhi [India], May 7 (ANI): Obesity, which is assuming epidemic proportions among children, is proving too much on their delicate bones and joints.

Full Story >>

Washington D.C. [USA], May 24 (ANI): A team of researchers has found that intestinal fungi, chronic liver damage, increase risk of death for the people with alcohol-related liver disease.

Full Story >>

Here's what dentists can tell about your health

Updated: May 23, 2017 16:46 IST     

Washington D.C. [USA], May 23 (ANI): A recent study has found that by using medical and dental records, researchers can identify what is the cause of disease and how the patients with certain diseases will respond to surgery, medication or other interventions.

Full Story >>

Trying to lose weight? Dieting may not help

Updated: May 23, 2017 15:08 IST     

Washington D.C. [USA], May 23 (ANI): Dieting has a little effect on losing weight, as a study finds that brain cells act as a trigger to prevent us burning calories when food is scarce.

Full Story >>

Washington D.C. [USA], May 23 (ANI): A study finds that late middle-aged people, with a family history and longer version of mitochondrial gene, encountered twice as much memory loss up to 10 years later as someone with a family history and a short version of the gene.

Full Story >>

New Delhi [India], May 22 (ANI): Global nutrition company Herbalife Nutrition undertook a survey on balanced nutrition in 12 markets across Asia Pacific and surveyed more than 6,000 consumers to understand eating habits, exercise and lifestyle habits among them.

Full Story >>

New device could detect inflammation in lungs

Updated: May 22, 2017 15:23 IST     

New Delhi [India], May 22 (ANI): To improve the management of asthma and other respiratory diseases, researchers have created a graphene-based sensor that could lead to earlier detection of looming asthma attacks.

Full Story >>

Clinical trial gives hope to lung disease patients

Updated: May 22, 2017 13:13 IST     

Washington D.C. [USA], May 22 (ANI): A 'game changing' clinical trial has given hope to patients with severe lung disease.

Full Story >>

Even moderate drinking may not keep heart disease at bay

Updated: May 22, 2017 12:29 IST     

Washington D.C. [USA], May 22 (ANI): If you feel having a glass of wine with dinner or moderately consuming any kind of alcohol is going to save you from heart disease, then you might have to think over it again!

Full Story >>

You may blame the polluted air for disrupted sleep!

Updated: May 22, 2017 11:43 IST     

Washington D.C. [USA], May 22 (ANI): If you are not having a sound sleep, then there might be fault in the air!

Full Story >>

Washington D.C. [USA], May 21 (ANI): A study has found that people aged between 18 to 49, with high systolic blood pressure over 140, are at greater risk of stroke, damage of kidneys and brain.

Full Story >>

Washington D.C. [USA], May 7 (ANI): A study has found that heart failure patients with a history of strokes are at a greater risk of depression, hospitalisation and death than those without such a history.

Full Story >>

Washington D.C. [USA], May 21 (ANI): More than one third of 1,400 people with high blood pressure have not been taking their blood pressure medication, according to a recent study.

Full Story >>